ASCENTAGE PHARMA GROUP INTERNATIONAL
AAPG · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,237 | $1,069 | $1,476 | $1,707 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $99 | $164 | $61 | $54 |
| Inventory | $7 | $16 | $9 | $4 |
| Other Curr. Assets | $25 | $25 | $17 | $59 |
| Total Curr. Assets | $1,474 | $1,344 | $1,636 | $1,885 |
| Property Plant & Equip (Net) | $906 | $957 | $650 | $854 |
| Goodwill | $25 | $25 | $25 | $25 |
| Intangibles | $76 | $85 | $84 | $60 |
| Long-Term Investments | $34 | $19 | $19 | $28 |
| Tax Assets | $44 | $60 | $54 | $52 |
| Other NC Assets | $59 | $10 | $362 | $36 |
| Total NC Assets | $1,144 | $1,156 | $1,194 | $1,055 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,618 | $2,500 | $2,830 | $2,940 |
| Liabilities | – | – | – | – |
| Payables | $92 | $72 | $96 | $71 |
| Short-Term Debt | $770 | $607 | $510 | $40 |
| Tax Payable | $10 | $8 | $7 | $3 |
| Deferred Revenue | $54 | $38 | $24 | $0 |
| Other Curr. Liab. | $0 | $0 | $3 | $59 |
| Total Curr. Liab. | $1,167 | $934 | $881 | $361 |
| LT Debt | $869 | $1,166 | $1,265 | $1,027 |
| Deferred Rev, NC | $276 | $288 | $219 | $243 |
| Deferred Tax Liab, NC | $5 | $11 | $12 | $14 |
| Other NC Liab. | $6 | $18 | $35 | $52 |
| Total NC Liab. | $1,177 | $1,496 | $1,540 | $1,344 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $30 | $23 | $17 | $18 |
| Total Liabilities | $2,344 | $2,430 | $2,422 | $1,705 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$5,771 | -$5,365 | -$4,439 | -$3,557 |
| AOCI | -$511 | -$504 | -$519 | -$551 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $264 | $60 | $409 | $1,235 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $10 | $10 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,618 | $2,500 | $2,830 | $2,940 |
| Net Debt | $402 | $704 | $300 | -$640 |